JEREMY ELLIOTT: Open Payments
NPI 1124043120 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 58 payments from 10 companies in 2025. Trend: 2023 $350 · 2024 $690 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $297 |
| AstraZeneca Pharmaceuticals LP | 5 | $198 |
| Lilly USA, LLC | 11 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Novo Nordisk Inc | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: AIRSUPRA, QULIPTA, MOUNJARO, JARDIANCE, UBRELVY, VRAYLAR, SHINGRIX, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
